ACUTE LYMPHOID LEUKEMIA RELAPSE

Clinical trials for ACUTE LYMPHOID LEUKEMIA RELAPSE explained in plain language.

Never miss a new study

Get alerted when new ACUTE LYMPHOID LEUKEMIA RELAPSE trials appear

Sign up with your email to follow new studies for ACUTE LYMPHOID LEUKEMIA RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids battling Leukemia's return

Disease control Recruiting now

This study is testing a drug called tafasitamab in children and teenagers with a very high-risk form of B-cell leukemia that has come back or hasn't responded to standard treatments like stem cell transplants. The main goals are to find a safe dose and see if the drug can help pr…

Matched conditions: ACUTE LYMPHOID LEUKEMIA RELAPSE

Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ACUTE LYMPHOID LEUKEMIA RELAPSE

Get alerted when new ACUTE LYMPHOID LEUKEMIA RELAPSE trials appear

New hope for kids battling Leukemia's return